Featured Story | | | Wednesday, July 5, 2017 Clementia Pharmaceuticals has filed to raise $115 million in an IPO. The Canadian biotech wants the cash to bankroll late-phase trials of an oral retinoic acid receptor gamma agonist it licensed from Roche. |
|
|
Top Stories Wednesday, July 5, 2017 Shire has decided to concentrate its U.S. operations into two main sites in Massachusetts—Cambridge and Lexington—in a move that will probably lead to the closure of some sites. Wednesday, July 5, 2017 Trillium Therapeutics is sharpening its focus and seeking new partners as it looks over its pipeline with an eye to the future. Wednesday, July 5, 2017 Senior politicians in the British government have called for the country to work closely with the European Medicines Agency after Brexit. The statement suggests the politicians are willing to stand up to colleagues pushing for a clean break from European regulation and want to reassure the industry they will minimize disruption. Wednesday, July 5, 2017 Californian outsourced research services provider Science Exchange has raised $28 million in its third funding round. Wednesday, July 5, 2017 Creavo Medical Technologies has raised $17 million to develop its heart attack test. The diagnostic is designed to help physicians more quickly rule out serious heart problems as the cause of chest pain, freeing hospitals from the need to take patients through the full cardiac testing pathway. Wednesday, July 5, 2017 For years, whistleblowers and their attorneys have been battling with Allergan over claims the company illegally promoted eye drugs by providing valuable consulting and other services to doctors. Their efforts proved worthwhile as the company agreed to hand over $13 million to settle kickback allegations with the U.S. and 19 states. | This week's sponsor is Cardinal Health. | | | [Webinar] Accelerating Clinical Trials through Adaptive Designs
Thursday, August 3 | 2pm ET / 11am PT
Early-phase adaptive clinical trials help companies accelerate product development by combining multiple clinical objectives into one study to deliver high-quality data and substantial time and cost savings. This interactive webinar will provide the framework for scientifically robust and efficient early-phase clinical drug development. Reserve Your Spot Today! |
| | | Merck KGaA will hand out €1.25 million to research projects in fertility via the Grant for Fertility Innovation this year. Statement Hospital specialty biopharma Recro Pharma has bought up exclusive global rights to two neuromuscular blocking agents, as well as a chemical reversal agent, from Cornell University. Release Array BioPharma's stock was up this morning after submitting two NDAs to the FDA for a combo of binimetinib and encorafenib in advanced, BRAF-mutant melanoma patients. Statement | |
|
Resources Sponsored By: Veeva Learn why 99% of respondents report the need to unify their clinical applications, including CTMS, EDC, eTMF, and study start-up. Sponsored By: HealthCore Gain critical insights into how to design and implement pragmatic trials and generate relevant, high-level real-world evidence. Learn when to conduct PTs, design considerations, ethical regulatory issues — and more. Sponsored By: Envigo Discover the factors that contribute to differential radiation sensitivity between the Rag2 and SCID models. Sponsored By: RTI Health Solutions In this webinar, we will introduce the rapidly-evolving within-subject clinical trial (WSCT) methods for early phase evidence generation that require fewer people, less time, and usually less funding than traditional early phase methods. Sponsored By: Veeva Join this global webinar to learn a new approach for demonstrating medical affairs' impact with better metrics - beyond reach and frequency, enabling launch success and better engagement with strategic KOL insights, and increasing your organization's share of voice in the healthcare landscape. Sponsored By: DocuSign DocuSign’s eSignature solutions modernize healthcare and life science organizations by eliminating paper and antiquated signature processes while meeting compliance requirements and reducing costs and errors. Sponsored By: DocuSign The patients who rely on your scientific leadership are expecting more. Sponsored By: DocuSign The U.S. Department of Justice has collected upwards of $17 billion in settlements from the healthcare industry since 2009, including more than $2 billion from a single life sciences company. Drug Development Boot Camp® 2017 November 15-16, 2017 | Boston, MA FierceBiotech 2nd Drug Development Forum September 25-27, 2017 | Boston, MA |
